Project 4: One-Carbon Metabolism, Oxidative Stress and As Toxicity

项目4:一碳代谢、氧化应激及毒性

基本信息

  • 批准号:
    8065867
  • 负责人:
  • 金额:
    $ 23.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-21 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

Two overarching themes of the biomedical research of this Superfund Program addressed in this project relate to a) the metabolism of arsenic (As) and b) As-induced oxidative stress. There is significant variability in progression from As exposure to clinical manifestations of disease. Several studies have led to the hypothesis that nutritional status may account for a substantial portion of this variability. Inorganic As is methylated via one-carbon metabolism, a biochemical pathway that is dependent on folate for recruitment of one-carbon groups. We wish to expand our studies, which have begun to characterize the impact of nutritional regulation of one-carbon metabolism on the inter-individual variability in As methylation. Glutathione (GSH), a key component of the primary antioxidant defense mechanism, and the electron donor for As reduction, is synthesized from homocysteine, and this synthesis is regulated by intermediates of onecarbon metabolism. A great deal of basic research, including salient work from members of our group, points to the growing belief that As depletes glutathione (GSH) and induces oxidative stress. However, the relationship between As exposure and oxidative stress has not been rigorously examined in human populations. The first specific aim of this proposal will utilize the repository of biological samples established by the Cohort Study (Project #2) to conduct a nested case-control study to identify modifiable risk factors (e.g. oxidative stress and/or hyperhomocysteinemia) related to increased susceptibility to As-induced skin lesions. The remaining specific aims will take advantage of the expansion of our study area (and installation of Asfree tube wells) in Projects #3 and #7 to recruit 375 new adults who are currently exposed to As. In Specific Aim 2, we will address a fundamental question: To what extent do urinary As metabolites reflect As metabolites in the circulation? In Specific Aim 3, we will conduct a cross-sectional study to test the hypotheses that higher concentrations of s-adenosylhomocysteine (SAH) and lower concentrations of GSH are associated with reduced As methylation. In Specific Aim 4, we propose to examine dose-response relationships between As exposure and oxidative stress. Finally, we will test the hypothesis that reduction of As exposure alleviates oxidative stress. The proposed studies have the potential to a) substantiate that As induces oxidative stress and depletes GSH in a human population, b) link As-induced oxidative stress and/or nutritional status to an arsenic-related clinical outcome, and c) expand our understanding of the mechanisms underlying these processes. Such findings would have significant implications for the identification of potential targeted interventions for preventing As-toxicity.
本项目涉及的超级基金项目生物医学研究的两个首要主题 涉及a)砷(As)的代谢和B)As诱导的氧化应激。存在显著的变异性 从砷暴露到疾病临床表现的进展。几项研究导致了 假设营养状况可以解释这种变异性很大一部分。无机As is 通过一碳代谢甲基化,这是一种依赖于叶酸的生物化学途径, 单碳基团。我们希望扩大我们的研究,这些研究已经开始描述 一碳代谢的营养调节对As甲基化的个体间变异性。 谷胱甘肽(GSH)是主要抗氧化防御机制的关键成分和电子供体 用于As还原的,由同型半胱氨酸合成,该合成受一碳的中间体调节, 新陈代谢.大量的基础研究,包括我们小组成员的突出工作, 指出,越来越多的人认为,作为消耗谷胱甘肽(GSH)和诱导氧化应激。但 砷暴露与氧化应激之间的关系尚未在人体中得到严格的研究 人口。 这项建议的第一个具体目标是利用由联合国建立的生物样品储存库, 队列研究(项目#2),进行巢式病例对照研究,以确定可改变的风险因素(例如: 氧化应激和/或高同型半胱氨酸血症)与对As诱导的皮肤损伤的易感性增加有关。 其余的具体目标将利用我们研究区域的扩展(以及Asfree的安装 威尔斯)招募375名目前暴露于砷的新成年人。在特定 目的2,我们将解决一个基本问题:在何种程度上尿砷代谢物反映砷 循环中的代谢物在具体目标3中,我们将进行一项横向研究,以测试 假设高浓度的s-腺苷高半胱氨酸(SAH)和低浓度的GSH 与As甲基化减少有关。在具体目标4中,我们建议检查剂量反应 砷暴露与氧化应激的关系。最后,我们将测试假设,减少 因为暴露会加重氧化应激。拟议的研究有可能a)证实, 在人群中诱导氧化应激并消耗GSH,B)连接As诱导的氧化应激和/或 营养状况与砷相关的临床结果,以及c)扩大我们对机制的理解 这些过程的基础。这些调查结果将对确定 潜在的有针对性的干预措施,以防止砷中毒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Gamble其他文献

Mary Gamble的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Gamble', 18)}}的其他基金

Interdisciplinary approaches for understanding the metabolic effects of arsenic and manganese
了解砷和锰代谢影响的跨学科方法
  • 批准号:
    10470810
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Metabolomic and nutrigenetic effects of folic acid supplementation and unmetabolized folic acid
叶酸补充剂和未代谢叶酸的代谢组学和营养遗传效应
  • 批准号:
    10604118
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Interdisciplinary approaches for understanding the metabolic effects of arsenic and manganese
了解砷和锰代谢影响的跨学科方法
  • 批准号:
    10263257
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Interdisciplinary approaches for understanding the metabolic effects of arsenic and manganese
了解砷和锰代谢影响的跨学科方法
  • 批准号:
    10064382
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Metabolomic and nutrigenetic effects of folic acid supplementation and unmetabolized folic acid
叶酸补充剂和未代谢叶酸的代谢组学和营养遗传效应
  • 批准号:
    10224696
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Metabolomic and nutrigenetic effects of folic acid supplementation and unmetabolized folic acid
叶酸补充剂和未代谢叶酸的代谢组学和营养遗传效应
  • 批准号:
    10386872
  • 财政年份:
    2020
  • 资助金额:
    $ 23.95万
  • 项目类别:
Biomarkers for Arsenic Toxicity: Genetics, Epigenetics and Folate
砷毒性的生物标志物:遗传学、表观遗传学和叶酸
  • 批准号:
    7778775
  • 财政年份:
    2010
  • 资助金额:
    $ 23.95万
  • 项目类别:
Biomarkers for Arsenic Toxicity: Genetics, Epigenetics and Folate
砷毒性的生物标志物:遗传学、表观遗传学和叶酸
  • 批准号:
    8197853
  • 财政年份:
    2010
  • 资助金额:
    $ 23.95万
  • 项目类别:
Biomarkers for Arsenic Toxicity: Genetics, Epigenetics and Folate
砷毒性的生物标志物:遗传学、表观遗传学和叶酸
  • 批准号:
    8391762
  • 财政年份:
    2010
  • 资助金额:
    $ 23.95万
  • 项目类别:
Biomarkers for Arsenic Toxicity: Genetics, Epigenetics and Folate
砷毒性的生物标志物:遗传学、表观遗传学和叶酸
  • 批准号:
    8019062
  • 财政年份:
    2010
  • 资助金额:
    $ 23.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了